DRI Capital Inc, based in Toronto, ON, is a pioneer in pharmaceutical royalty monetization, focusing on building a diversified portfolio of interests in medicines that effectively treat unmet medical needs. Their expertise lies in tailored offerings, serving as a best-in-class partner for investors and innovators alike. As a smart capital allocator, DRI Capital Inc acquires dependable, patent-protected cash flow streams derived from the sales of crucial drugs across multiple therapeutic areas. Their portfolio is designed to actively drive value creation by sourcing royalty streams on medically necessary products with long-term patent protection and high growth potential. Investors benefit from uniquely favorable exposure through DRI Capital Inc's diversified, risk-mitigated portfolio of therapeutic assets, aiming to generate attractive returns and significant growth potential. The company's commitment to innovation and responsibility underpins its approach to creating value in the pharmaceutical industry. Generated from the website content

Swarovski Canada Limited

CNA Canadian Operations

Benefit

Cadillac Fairview